These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9696717

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors.
    Clavé P, González A, Moreno A, López R, Farré A, Cussó X, D'Amato M, Azpiroz F, Lluís F.
    Gastroenterology; 1998 Sep; 115(3):597-604. PubMed ID: 9721157
    [Abstract] [Full Text] [Related]

  • 3. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans.
    Zerbib F, Bruley Des Varannes S, Scarpignato C, Leray V, D'Amato M, Rozé C, Galmiche JP.
    Am J Physiol; 1998 Dec; 275(6):G1266-73. PubMed ID: 9843762
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction.
    Hopman WP, Jansen JB, Rosenbusch G, Lamers CB.
    Am J Clin Nutr; 1984 Mar; 39(3):356-9. PubMed ID: 6695835
    [Abstract] [Full Text] [Related]

  • 6. Role of CCK(A) receptors in postprandial lower esophageal sphincter function in morbidly obese subjects.
    Hirsch DP, Mathus-Vliegen EM, Holloway RH, Fakhry N, D'Amato M, Boeckxstaens GE.
    Dig Dis Sci; 2002 Nov; 47(11):2531-7. PubMed ID: 12452391
    [Abstract] [Full Text] [Related]

  • 7. Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man.
    Masclee AA, Jansen JB, Rovati LC, Lamers CB.
    Dig Dis Sci; 1993 Oct; 38(10):1889-92. PubMed ID: 8404410
    [Abstract] [Full Text] [Related]

  • 8. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB.
    Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Medium chain triglycerides activate distal but not proximal gut hormones.
    Vu MK, Verkijk M, Muller ES, Biemond I, Lamers CB, Masclee AA.
    Clin Nutr; 1999 Dec; 18(6):359-63. PubMed ID: 10634921
    [Abstract] [Full Text] [Related]

  • 14. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers.
    Niederau C, Schwarzendrube J, Lüthen R, Niederau M, Strohmeyer G, Rovati L.
    Pancreas; 1992 Dec; 7(1):1-10. PubMed ID: 1557335
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Medium-chain triacylglycerols enhance release of cholecystokinin in chicks.
    Mabayo RT, Furuse M, Yang SI, Okumura J.
    J Nutr; 1992 Aug; 122(8):1702-5. PubMed ID: 1640264
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.